Interviews

In this interview we speak to Deepali Kumar about vaccination in the immunocompromised population, including guideline updates, understanding immunology and the future of this field.

Emerging evidence has suggested that B cells and humoral immunity could modulate the immune response to intracellular pathogens. We speak to Babak Javid about his research on this topic and the importance of learning about immune factors in order to develop vaccination strategies and to understand latent TB.

In this interview we speak to Kelly Gebo, Chief Medical and Scientific Officer for the All of Us Research Program,…

Precision medicine is an approach to patient care that aims for the right intervention, in the right patient, at the right time – but what impact could this have on the treatment of infectious diseases? We asked Mathias Pletz about this approach to treatment, the research he’s directing at his institute and what the challenges are in this field.

In October 2019 researchers from Brazil identified a new parasite, which presented with similar symptoms to visceral leishmaniasis. To discover more about this novel parasite and other parasitic diseases in Brazil, we interviewed Sandra Maruyama from the Federal University of São Carlos (UFSCar; São Paulo, Brazil) about her research and the future of this field.

Chimeric antigen receptor (CAR) T-cell therapy is a highly complex and innovative treatment that involves collecting and using the patients’ own immune cells to treat their cancers. In this interview we speak to M. Bilal Abid about what impact the gut microbiome could have on this immune-engaging therapy, and the regulations currently surrounding the use of probiotics.

In this interview, we speak to Jenn Edwards from the Abigail Wexner Research Institute (OH, USA) about her research using the primary human epithelial cell models to examine Neisseria gonorrhoeae infections, the potential for vaccination against gonorrhea and a possible host-targeted therapy for this infection.

In this article, we explore the crucial role of shared decision-making in HIV treatment and hear from David Hardy (Johns…

In this interview we speak to Keith Kaye, from the University of Michigan (MI, USA) about the RESTORE-IMI 2 study, its results and why ICU patients represent an unmet need.

Sepsis, a condition associated with significant morbidity and mortality, has been increasingly associated with the gut microbiome. In this interview…